The riskbenefit assessment for wellness or anti-aging interventions may differ substantially from that applied to disease-specific therapeutic indications, given the differing clinical objectives and risk tolerances
So, at least its positive with that
To view a copy of this licence, visit About this article Cite this article Kong, YX., Li, ZS., Liu, YB
PubMed laboratory research record [PMID: 25486197] PubMed record related to this compound for laboratory literature review
Some people end up seeing results within the first week
Epitalons ability to reactivate telomerase has been demonstrated using the Telomeric Repeat Amplification Protocol (TRAP) assay in two key cell models: HeLa cells (telomerase-positive cancer cell line) and Human fetal lung fibroblasts (602/17)